RCM
JBIO

RA Capital Management’s Jade Biosciences JBIO Stock Holding History

RA Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.6M Hold
3,671,083
– – 0.55% 34
2025
Q4 		$56.6M Buy
3,671,083
+2,608,757
+246% +$30.6M 0.58% 33
2025
Q3 		$9.17M Hold
1,062,326
– – 0.11% 52
2025
Q2 		$10.6M Buy
1,062,326
+799,695
+304% +$27.2M 0.18% 44
2025
Q1 		$23.1M Hold
262,631
– – 0.39% 38
2024
Q4 		$24.4M Hold
262,631
– – 0.32% 52
2024
Q3 		$19.2M Hold
262,631
– – 0.22% 55
2024
Q2 		$15.3M Buy
262,631
+26,517
+11% +$17.6M 0.2% 55
2024
Q1 		$244M Hold
236,114
– – 3.11% 5
2023
Q4 		$187M Hold
236,114
– – 2.92% 6
2023
Q3 		$112M Hold
236,114
– – 2.21% 8
2023
Q2 		$142M Hold
236,114
– – 2.68% 7
2023
Q1 		$167M Hold
236,114
– – 3.77% 5
2022
Q4 		$242M Hold
236,114
– – 4.91% 3
2022
Q3 		$137M Hold
236,114
– – 2.92% 6
2022
Q2 		$129M Hold
236,114
– – 3.44% 4
2022
Q1 		$151M Hold
236,114
– – 3.31% 3
2021
Q4 		$97.4M Hold
236,114
– – 1.72% 16
2021
Q3 		$173M Hold
236,114
– – 2.4% 10
2021
Q2 		$189M Buy
+236,114
New +$189M 3.03% 6

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM